There's a moment in every company's life when the work stops feeling experimental and starts feeling inevitable. SMX (NASDAQ:SMX) just hit that moment. The company that taught matter how to speak is ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

Michael Buck, PhD, professor of biochemistry in the Jacobs School, recently received NIH funding to explore how molecular readers of DNA access and activate seemingly hidden genes.

Scientists are hopeful it will improve understanding of how genes work, what goes wrong in disease, and how to fix it.

MASPIN (“tumor suppressor shield”): MASPIN is a natural defense protein that blocks tumor invasion, regulates cell migration and angiogenesis, promotes apoptosis, and enhances treatment sensitivity.

MIAMI, FLORIDA / ACCESS Newswire / October 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that ...

Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...

The third of Lightfighter's co-founders is chief technology officer Nick Lambert, whose background includes electric motor technology and nine years overseeing quality control and new-model ...